News media registration opens for ENDO 09 in Washington, D.C.
Chevy Chase, MD The Endocrine Society's 91st Annual Meeting, ENDO 09 will be held at the Walter E Washington Convention Center in Washington, DC, June 10-13, 2009. Approximately 7,500 scientists and clinicians from all over the world are expected to assemble for this premier meeting of hormone res...Indevus Pharmaceuticals Announces Definitive Merger Agreement With Endo Pharmaceuticals
Company to Host Conference Call January 6, 2009 at 8:30 a.m. EST LEXINGTON, Mass., Jan. 5 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV ) today announced that it has entered into a definitive merger agreement under which Endo Pharmaceuticals Holdings, Inc. will comm...Bioniche Repays Revolving Credit Facility
...NC), a research-based, technology-driven Canadian biopharmaceutical company, today reported that it has received a US$20 million up-front payment from endo Pharmaceuticals per the licensing agreement related to Urocidin(TM) (announced on July 10, 2009). The Company has used a portion of this payment to re...Endo Pharmaceuticals to Announce Second Quarter 2009 Financial Results on July 30, 2009
...CHADDS FORD, Pa., July 1 /PRNewswire-FirstCall/ -- endo Pharmaceuticals (Nasdaq: ENDP ) will announce it...stor Relations section of the website. About endo endo Pharmaceuticals is a specialty pharmaceutical comp...HealthTronics, Inc. Commences Exchange Offer for Endocare, Inc. Shares
...d IRVINE, Calif., June 17 /PRNewswire-FirstCall/ -- HealthTronics, Inc. ("HealthTronics") (Nasdaq: HTRN ) and Endocare, Inc. ("Endocare") (Nasdaq: endo ) announced today that HealthTronics has commenced an exchange offer for all of the outstanding shares of Endocare common stock pursuant to their prev...Endo Pharmaceuticals to Present at Goldman Sachs 30th Annual Healthcare Conference
...CHADDS FORD, Pa., June 5 /PRNewswire-FirstCall/ -- endo Pharmaceuticals (Nasdaq: ENDP ) announced today ...o.com under the investors section. About endo endo Pharmaceuticals is a specialty pharmaceutical comp...Endo Announces Compensation for New CFO Alan Levin
...CHADDS FORD, Pa., May 29 /PRNewswire-FirstCall/ -- endo Pharmaceuticals (Nasdaq: ENDP ) announced today ...k units and an option to purchase 80,000 shares of endo common stock in connection with his appointment as...ficer. These grants are being made outside of the endo 2007 stock incentive plan but are subject to the t...Endocare Receives NASDAQ Deficiency Letter Regarding Stockholders' Equity
... IRVINE, Calif., May 27 /PRNewswire-FirstCall/ -- Endocare, Inc. (Nasdaq: endo ), an innovative medical device company focused on the development of minimally invasive technologies for tissue and tumor ablation, today announced t...AMR Research Announces Final Agenda for Sold-Out Supply Chain Executive Conference
...Moore, President, Sisters of Mercy Health System Wesley Story, Director of Marketing Operations, Wal-Mart Dan Carbery, SVP Operations, endo Pharmaceuticals and Generics For more information about the conference, please visit: http://www.amrresearch.com/Events/Conferenc...Endocare Reports 2009 First Quarter Financial Results
... IRVINE, Calif., May 15 /PRNewswire-FirstCall/ -- Endocare, Inc. (Nasdaq: endo ), an innovative medical device company focused on the development of minimally invasive technologies used by urologists and interventional radiologis...Teikoku Pharma USA Acquires Travanti Pharma Inc.
... efforts in two therapeutic areas; Pain Management and CNS. Teikoku's main product is Lidoderm(R) (Lidocaine 5% Patch) for PHN, in collaboration with endo Pharmaceuticals in the US, Grunenthal GmbH in Europe, Mundipharma in South East Asia and SK Pharma for Korea. Teikoku's commitment is to expand t...Endo to Present at Bank of America and Merrill Lynch 2009 Health Care Conference
... CHADDS FORD, Pa., May 6 /PRNewswire-FirstCall/ -- endo Pharmaceuticals (Nasdaq: ENDP ) announced today ...o.com under the investors section. ABOUT endo endo Pharmaceuticals is a specialty pharmaceutical comp...Endo Pharmaceuticals Reports First Quarter 2009 Financial Results
...ADDS FORD, Pa., April 29 /PRNewswire-FirstCall/ -- endo Pharmaceuticals (Nasdaq: ENDP ) today reported f...bruary 23, 2009 for Indevus Pharmaceuticals, which endo acquired during the quarter. Net sales during... Holveck, president and chief executive officer of endo Pharmaceuticals. "I believe our broader therapeuti...Endo Pharmaceuticals Completes Acquisition of Indevus Pharmaceuticals
...ADDS FORD, Pa., March 23 /PRNewswire-FirstCall/ -- endo Pharmaceuticals (Nasdaq: ENDP ) today announced ... its acquisition of Indevus Pharmaceuticals, Inc. endo acquired Indevus through a tender offer and subseq...ain regulatory and sales milestones. About endo ...Endo Pharmaceuticals Announces Successful Completion of Tender Offer for Indevus Pharmaceuticals
...ADDS FORD, Pa., March 19 /PRNewswire-FirstCall/ -- endo Pharmaceuticals (Nasdaq: ENDP ) today announced ..., the depositary for the tender offer, has advised endo that, as of 5 p.m., New York City time, on March 1...89.155% of Indevus' issued and outstanding shares. endo has accepted for payment and promptly paid for all...Alexza Reports 2008 Year-End Financial Results and Updates Clinical Pipeline Status
...nder the now terminated development agreement with endo Pharmaceuticals, and increased share-based compens...es. In January 2009, Alexza mutually agreed with endo Pharmaceuticals, Inc. to terminate the license agr...ts to AZ-003 reverting back to Alexza. Alexza and endo entered into this license agreement in December 20...NewCardio Elects Michael E. Hanson to Board of Directors
...the board of directors, compensation and audit committees, of Indevus Pharmaceuticals, culminating with Indevus' 2009 Definitive Merger Agreement with endo Pharmaceuticals Holdings, Inc. From 2002 to 2006, Mr. Hanson was a member of the board of directors, compensation and audit committees, of GlycoGenes...Endocare Reports 2008 Annual and Fourth Quarter Financial Results
... IRVINE, Calif., March 6 /PRNewswire-FirstCall/ -- Endocare, Inc. (Nasdaq: endo ), an innovative medical device company focused on the development of minimally invasive technologies used by urologists and interventional radiologis...Endo Pharmaceuticals Announces Extension of its Tender Offer for Shares of Indevus Pharmaceuticals
...HADDS FORD, Pa., March 2 /PRNewswire-FirstCall/ -- endo Pharmaceuticals (Nasdaq: ENDP ) announced today ..., the depositary for the tender offer, has advised endo that, as of 5:00 p.m., New York City time, on Febr...er offer, together with the shares already held by endo and its affiliates, exceeds 90% of Indevus' outsta...Endo Pharmaceuticals Reports Fourth Quarter and Full-Year Financial Results
...HADDS FORD, Pa., Feb. 27 /PRNewswire-FirstCall/ -- endo Pharmaceuticals (Nasdaq: ENDP ) today reported d...e same period in 2007. R&D Update endo recently announced three new research collaboratio...motor neurons. Under the terms of this agreement, endo has received exclusive world-wide rights to the te...Endo Licenses Novel Pain Therapy from Grunenthal
...HADDS FORD, Pa., Feb. 27 /PRNewswire-FirstCall/ -- endo Pharmaceuticals (Nasdaq: ENDP ) announced today ...er the license agreement signed by both companies, endo will pay Grunenthal an upfront cash payment as wel.... The product will be manufactured by Grunenthal. endo will participate with Grunenthal in joint product ...Endo Pharmaceuticals Returns Product Rights to TRANSDUR(TM)-Sufentanil to DURECT
... Corporation (Nasdaq: DRRX ) today reported that endo Pharmaceuticals (Nasdaq: ENDP ) has given notice...tch in development intended to treat chronic pain. endo and DURECT recently completed a successful end-of-...rminate the license agreement entered into between endo and DURECT, and has committed to assist in an orde...Endo Pharmaceuticals Appoints William Montague to Board of Directors
...HADDS FORD, Pa., Feb. 26 /PRNewswire-FirstCall/ -- endo Pharmaceuticals (Nasdaq: ENDP ) announced today ...lar markets. His appointment brings the number of endo board members to eight. Mr. Montague will serve a...nvaluable strategic advice as we continue to build endo through developing new products, entering new mark...Endo and Penwest Announce Settlement of Opana(R) ER Litigation
... DANBURY, Conn., Feb. 20 /PRNewswire-FirstCall/ -- endo Pharmaceuticals (Nasdaq: ENDP ), and Penwest Pha...hone hydrochloride) Extended Release Tablets CII. endo and Penwest have agreed to dismiss their suit with...prejudice. Under the terms of the settlement, endo and Penwest have agreed to grant Actavis a license...Indevus Pharmaceuticals Announces First Quarter Fiscal 2009 Financial Results
...mas of the prostate. Merger Agreement with endo Pharmaceuticals On January 5, 2009, the Com...ny entered into a definitive merger agreement with endo Pharmaceuticals Holdings Inc. ("Endo"), a Delaware...s (less any required withholding taxes) payable by endo in the future upon achievement of certain mileston...Endocare to Present at 2nd Annual OneMedForum
... IRVINE, Calif., Jan. 7 /PRNewswire-FirstCall/ -- Endocare, Inc. (Nasdaq: endo ), an innovative medical device company focused on the development of minimally invasive technologies for tissue and tumor ablation, today announced t...Endo Pharmaceuticals to Acquire Indevus Pharmaceuticals
...LEXINGTON, Mass., Jan. 5 /PRNewswire-FirstCall/ -- endo Pharmaceuticals (Nasdaq: ENDP ) and Indevus Phar...y have entered into a merger agreement under which endo will commence a tender offer to acquire 100 percen...ug delivery technology. We believe this will make endo a stronger competitor, a more valuable health care...Strategic Domain Announces 30-Point Search Engine Optimization Check-up for Web Sites
...n initiatives in the US and globally. A partial list of their clients include American Standard, Benjamin Moore, CV Therapeutics, Dassault Falcon Jet, endo Pharmaceuticals, EUSA Pharma, Johnson & Johnson, the National Community Pharmacists Association (NCPA), Pharmacist e-Link, Procter & Gamble, a...Alexza Pharmaceuticals Announces Upcoming Conference Participation and Webcasts
... Product candidates that have completed Phase 1 testing are AZ-003 (Staccato fentanyl) for the treatment of breakthrough pain, which is partnered with endo Pharmaceuticals in North America, and AZ-007 (Staccato zaleplon) for the treatment of insomnia. In addition, AZ-002 (Staccato alprazolam) has complete...Endocare and Galil Medical Sign Definitive Merger Agreement
... with Current Institutional Investors IRVINE, Calif. and YOKNEAM, Israel, Nov. 10 /PRNewswire-FirstCall/ -- Endocare, Inc. (Nasdaq: endo ) and privately held Galil Medical, Ltd., both innovative medical device companies, today announced the signing of a definitive merger agreement. The ...Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates
...lexza is jointly developing Staccato fentanyl with endo Pharmaceuticals, Inc., or Endo, for the treatment of breakthrough pain. endo is responsible for regulatory, pre-clinical and cl...ment of breakthrough pain, which is partnered with endo Pharmaceuticals in North America, and AZ-007 (Stac...